Phebra, University of Wollongong partner to develop cancer therapies

Phebra and University of Wollongong Join Forces to Develop Cancer Therapies Pharmaceutical company Phebra has recently announced a groundbreaking six-year collaboration with the University of Wollongong (UOW) in Australia. This partnership aims to advance the development of innovative cancer therapies, offering new hope in the fight against this devastating disease. Phebra is a leading player…

Read More

Surf Lifesaving Awards for Illawarra volunteers

Surf Lifesaving Awards for Illawarra volunteers The recent Surf Life Saving NSW’s ‘Awards of Excellence’ highlighted and recognized the invaluable contributions of Illawarra and South Coast Branch volunteers. Among the winners, Bellambi SLSC stood out with four category wins. Brody Robertson was awarded for the second consecutive year as the Youth Surf Lifesaver of the…

Read More

Voice advocate Pat Farmer arrives in Wollongong on 14,400-km run around Australia

Voice advocate Pat Farmer arrives in Wollongong on 14,400-km run around Australia Pat Farmer, a well-known voice advocate, has successfully arrived in Wollongong as part of his incredible 14,400-kilometer run around Australia. Farmer, who is an accomplished ultra-marathon runner and former politician, undertook this extraordinary journey to raise awareness about the importance of communication and…

Read More

‘Very bulky’: ‘Boutique’ North Wollongong apartment block faces rejection

‘Boutique’ North Wollongong Apartment Block Faces Rejection A proposed apartment block in North Wollongong is facing potential rejection due to concerns over its size. The development consists of ten units, with one unit designated for the applicant and their family, and the remaining units varying between three and four bedrooms. Notably, no one or two-bedroom…

Read More

Phebra partners with University of Wollongong to develop drug for leukemia, pancreatic cancer

Phebra partners with University of Wollongong to develop drug for leukemia, pancreatic cancer Australian pharmaceutical firm Phebra has joined forces with the University of Wollongong (UOW) in a six-year collaboration agreement to conduct research and development (R&D) and trials for the treatment of acute myeloid leukemias and pancreatic cancer. Phebra’s CEO, Andre Vlok, expressed satisfaction…

Read More